Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Impact of Hepatic Dysfunction on Vancomycin Area Under the Concentration–Time Curve Estimation and the Need for Early Therapeutic Drug Monitoring. Local targets link to admitted publications; unresolved targets remain external evidence.
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America
10.1086/599376 · 2009 · External reference
Vancomycin: a history
10.1086/491709 · 2006 · External reference
Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children
10.1093/cid/ciq146 · 2011 · External reference
The nephrotoxicity of vancomycin
10.1002/cpt.726 · 2017 · External reference
Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review
10.1007/s00228-012-1259-9 · 2012 · External reference
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
10.1093/ajhp/zxaa036 · 2020 · External reference
Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
10.3390/pharmaceutics14030489 · 2022 · External reference
Conductance of area under the concentration–time curve estimations of vancomycin with limited sampling by a newly-developed web application
10.1007/s11095-021-03030-y · 2021 · External reference
Prediction of creatinine clearance from serum creatinine
1976 · External reference
Creatine and creatinine metabolism
10.1152/physrev.2000.80.3.1107 · 2000 · External reference
Enzymes of creatine biosynthesis, arginine, and methionine metabolism in normal and malignant cells
10.1111/j.1742-4658.2008.06718.x · 2008 · External reference
Assessing renal function in cirrhotic patients: problems and pitfalls
10.1053/ajkd.2003.50035 · 2003 · External reference
What is the best alternative to inulin clearance to estimate GFR in patients with decompensated alcoholic cirrhosis?
10.1093/ndt/gfq248 · 2010 · External reference
Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients
10.1093/ndt/gfi305 · 2006 · External reference
Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?
10.1155/2006/858053 · 2006 · External reference
Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study
10.1016/0002-9343(87)90156-2 · 1987 · External reference
Value of liver function tests in cirrhosis
10.1016/j.jceh.2021.11.004 · 2022 · External reference
Impaired albumin function: a novel potential indicator for liver function damage?
10.1080/07853890.2019.1693056 · 2019 · External reference
Loss of liver function in chronic liver disease: an identity crisis
10.1016/j.jhep.2022.09.001 · 2023 · External reference
New insights about albumin and liver disease
10.5604/01.3001.0012.0916 · 2018 · External reference
Biliary tract cancer
10.1016/j.ejso.2024.108489 · 2025 · External reference
Acute cholangitis
10.1016/s0039-6109(16)45285-0 · 1990 · External reference
Transection of the oesophagus for bleeding oesophageal varices
10.1002/bjs.1800600817 · 1973 · External reference
Evaluation of vancomycin dosing in patients with cirrhosis: beginning de-liver-ations about a new nomogram
10.1177/0018578718772266 · 2019 · External reference
The risk of vancomycin toxicity in patients with liver impairment
10.1186/s12941-020-00354-2 · 2020 · External reference
Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury
2012 · External reference
The assessment of liver disease utilizing a panel of liver function tests
2022 · External reference
Model-informed precision dosing of vancomycin for rapid achievement of target area under the concentration–time curve: a simulation study
10.1111/cts.13626 · 2023 · External reference
Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application
10.1016/j.jiac.2024.05.014 · 2024 · External reference
Albumin synthesis by human liver cells: its morphological demonstration
10.1016/s0016-5085(19)33181-6 · 1972 · External reference
Hypoalbuminemia
10.1007/s11739-012-0802-0 · 2012 · External reference
Population pharmacokinetics of vancomycin in Japanese adult patients
10.1097/00007691-199804000-00003 · 1998 · External reference
Spectrum of anemia associated with chronic liver disease
10.3748/wjg.15.4653 · 2009 · External reference
Association of liver cirrhosis severity with anemia: does it matter?
2020 · External reference
Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring
10.1016/j.jiac.2025.102821 · 2025 · External reference